Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tadao Iburi is active.

Publication


Featured researches published by Tadao Iburi.


Thyroid | 2012

Diagnostic Criteria, Clinical Features, and Incidence of Thyroid Storm Based on Nationwide Surveys

Takashi Akamizu; Tetsurou Satoh; Osamu Isozaki; Atsushi Suzuki; Shu Wakino; Tadao Iburi; Kumiko Tsuboi; Tsuyoshi Monden; Tsuyoshi Kouki; Hajime Otani; Satoshi Teramukai; Ritei Uehara; Yosikazu Nakamura; Masaki Nagai; Masatomo Mori

BACKGROUND Thyroid storm (TS) is life threatening. Its incidence is poorly defined, few series are available, and population-based diagnostic criteria have not been established. We surveyed TS in Japan, defined its characteristics, and formulated diagnostic criteria, FINAL-CRITERIA1 and FINAL-CRITERIA2, for two grades of TS, TS1, and TS2 respectively. METHODS We first developed diagnostic criteria based on 99 patients in the literature and 7 of our patients (LIT-CRITERIA1 for TS1 and LIT-CRITERIA2 for TS2). Thyrotoxicosis was a prerequisite for TS1 and TS2 as well as for combinations of the central nervous system manifestations, fever, tachycardia, congestive heart failure (CHF), and gastrointestinal (GI)/hepatic disturbances. We then conducted initial and follow-up surveys from 2004 through 2008, targeting all hospitals in Japan, with an eight-layered random extraction selection process to obtain and verify information on patients who met LIT-CRITERIA1 and LIT-CRITERIA2. RESULTS We identified 282 patients with TS1 and 74 patients with TS2. Based on these data and information from the Ministry of Health, Labor, and Welfare of Japan, we estimated the incidence of TS in hospitalized patients in Japan to be 0.20 per 100,000 per year. Serum-free thyroxine and free triiodothyroine concentrations were similar among patients with TS in the literature, Japanese patients with TS1 or TS2, and a group of patients with thyrotoxicosis without TS (Tox-NoTS). The mortality rate was 11.0% in TS1, 9.5% in TS2, and 0% in Tox-NoTS patients. Multiple organ failure was the most common cause of death in TS1 and TS2, followed by CHF, respiratory failure, arrhythmia, disseminated intravascular coagulation, GI perforation, hypoxic brain syndrome, and sepsis. Glasgow Coma Scale results and blood urea nitrogen (BUN) were associated with irreversible damages in 22 survivors. The only change in our final diagnostic criteria for TS as compared with our initial criteria related to serum bilirubin concentration >3 mg/dL. CONCLUSIONS TS is still a life-threatening disorder with more than 10% mortality in Japan. We present newly formulated diagnostic criteria for TS and clarify its clinical features, prognosis, and incidence based on nationwide surveys in Japan. This information will help diagnose TS and in understanding the factors contributing to mortality and irreversible complications.


Endocrine Journal | 2016

2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition)

Tetsurou Satoh; Osamu Isozaki; Atsushi Suzuki; Shu Wakino; Tadao Iburi; Kumiko Tsuboi; Naotetsu Kanamoto; Hajime Otani; Yasushi Furukawa; Satoshi Teramukai; Takashi Akamizu

Thyroid storm is an endocrine emergency which is characterized by multiple organ failure due to severe thyrotoxicosis, often associated with triggering illnesses. Early suspicion, prompt diagnosis and intensive treatment will improve survival in thyroid storm patients. Because of its rarity and high mortality, prospective intervention studies for the treatment of thyroid storm are difficult to carry out. We, the Japan Thyroid Association and Japan Endocrine Society taskforce committee, previously developed new diagnostic criteria and conducted nationwide surveys for thyroid storm in Japan. Detailed analyses of clinical data from 356 patients revealed that the mortality in Japan was still high (∼11%) and that multiple organ failure and acute heart failure were common causes of death. In addition, multimodal treatment with antithyroid drugs, inorganic iodide, corticosteroids and beta-adrenergic antagonists has been suggested to improve mortality of these patients. Based on the evidence obtained by nationwide surveys and additional literature searches, we herein established clinical guidelines for the management of thyroid storm. The present guideline includes 15 recommendations for the treatment of thyrotoxicosis and organ failure in the central nervous system, cardiovascular system, and hepato-gastrointestinal tract, admission criteria for the intensive care unit, and prognostic evaluation. We also proposed preventive approaches to thyroid storm, roles of definitive therapy, and future prospective trial plans for the treatment of thyroid storm. We hope that this guideline will be useful for many physicians all over the world as well as in Japan in the management of thyroid storm and the improvement of its outcome.


Clinical Endocrinology | 2016

Treatment and management of thyroid storm: analysis of the nationwide surveys: The taskforce committee of the Japan Thyroid Association and Japan Endocrine Society for the establishment of diagnostic criteria and nationwide surveys for thyroid storm.

Osamu Isozaki; Tetsurou Satoh; Shu Wakino; Atsushi Suzuki; Tadao Iburi; Kumiko Tsuboi; Naotetsu Kanamoto; Hajime Otani; Yasushi Furukawa; Satoshi Teramukai; Takashi Akamizu

Thyroid storm (TS) is a life‐threatening endocrine emergency. This study aimed to achieve a better understanding of the management of TS by analyzing therapeutic modalities and prognoses reported by nationwide surveys performed in Japan.


Journal of Diabetes Investigation | 2018

Real-life glycemic control in patients with type 2 diabetes treated with insulin therapy: A prospective, longitudinal cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 9])

Naotaka Fujita; Yosuke Yamamoto; Yasuaki Hayashino; Hirohito Kuwata; Shintaro Okamura; Tadao Iburi; Miyuki Furuya; Masako Kitatani; Shin Yamazaki; Hitoshi Ishii; Satoru Tsujii; Nobuya Inagaki; Shunichi Fukuhara

We investigated the association between four insulin regimens, and increase in glycated hemoglobin (HbA1c) and insulin dose in a real‐life clinical setting because there are no data about them among insulin regimens.


Journal of Diabetes and Its Complications | 2017

Association between dipstick hematuria and decline in estimated glomerular filtration rate among Japanese patients with type 2 diabetes: A prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 14)]

Tsuyoshi Mashitani; Yasuaki Hayashino; Shintaro Okamura; Masako Kitatani; Miyuki Furuya; Tadao Iburi; Satoru Tsujii; Hitoshi Ishii

AIMS To assess the association between dipstick hematuria and estimated glomerular filtration rate (eGFR) decline in Japanese patients with type 2 diabetes. METHODS Longitudinal data were obtained from 3068 Japanese patients with type 2 diabetes. To assess the independent association between dipstick hematuria and eGFR decline, we used Cox proportional hazard model adjusted for potential confounders. RESULTS Median follow-up period was 699.7days. Mean age, body mass index (BMI), and HbA1c level were 65.7years, 24.6kg/m2, and 7.5% (58.1mmol/mol), respectively. Positive dipstick hematuria was significantly associated with baseline eGFR and severity of albuminuria (p<0.001). The multivariable-adjusted hazard ratio for eGFR decline in patients with dipstick hematuria compared with those without dipstick hematuria was 2.19 [95% confidence interval (CI): 1.22-3.91]; this association remained significant even after the exclusion of patients who did not have diabetic retinopathy (hazard ratio: 2.39; 95% CI: 1.13-5.04). CONCLUSION Positive dipstick hematuria was associated with severity of albuminuria and renal function. A significant association was found between dipstick hematuria and increased risk of eGFR decline among patients with type 2 diabetes. Therefore, our results suggest that dipstick hematuria is perhaps indicative of more severe diabetic nephropathy.


Biomedical Research-tokyo | 2007

Laughter up-regulates the genes related to NK cell activity in diabetes

Takashi Hayashi; Satoru Tsujii; Tadao Iburi; Tamiko Tamanaha; Keiko Yamagami; Rieko Ishibashi; Miyo Hori; Shigeko Sakamoto; Hitoshi Ishii; Kazuo Murakami


Acta Diabetologica | 2015

Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 8)

Tsuyoshi Mashitani; Yasuaki Hayashino; Shintaro Okamura; Masako Kitatani; Miyuki Furuya; Tadao Iburi; Hirohito Kuwata; Satoru Tsujii; Hitoshi Ishii


Thyroid | 2012

Diagnostic criteria and clinico-epidemiological features of thyroid storm based on a nationwide survey

Takashi Akamizu; Tetsurou Satoh; Osamu Isozaki; Atsushi Suzuki; Shu Wakino; Tadao Iburi; Kumiko Tsuboi; Tsuyoshi Monden; Tsuyoshi Kouki; Hajime Otani; Satoshi Teramukai; Ritei Uehara; Yoshikazu Nakamura; Masaki Nagai; Masatomo Mori


Thyroid | 2012

Erratum: Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys (Thyroid (2012) 22:7 (661-669))

Takashi Akamizu; Tetsurou Satoh; Osamu Isozaki; Atsushi Suzuki; Shu Wakino; Tadao Iburi; Kumiko Tsuboi; Tsuyoshi Monden; Tsuyoshi Kouki; Hajime Otani; Satoshi Teramukai; Ritei Uehara; Yosikazu Nakamura; Masaki Nagai; Masatomo Mori


Internal Medicine | 2014

Switching from Insulin to Liraglutide Improved Glycemic Control and the Quality of Life Scores in a Case of Type 2 Diabetes and Active Crohn's Disease

Hirohito Kuwata; Satoru Tsujii; Naotaka Fujita; Shintaro Okamura; Tadao Iburi; Tsuyoshi Mashitani; Masako Kitatani; Miyuki Furuya; Yasuaki Hayashino; Hitoshi Ishii

Collaboration


Dive into the Tadao Iburi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atsushi Suzuki

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar

Hajime Otani

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satoshi Teramukai

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takashi Akamizu

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge